Brett A. Giffin - Nov 8, 2022 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)

Role
Chief Commercial Officer
Signature
/s/ John Sprague, Attorney-in-fact
Stock symbol
TTOO
Transactions as of
Nov 8, 2022
Transactions value $
-$2,317
Form type
4
Date filed
11/22/2022, 03:00 PM
Previous filing
Apr 11, 2022
Next filing
Nov 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTOO Common Stock Options Exercise +3.33K +1572.17% 3.55K Nov 8, 2022 Direct F1
transaction TTOO Common Stock Sale -$2.32K -1.29K -36.45% $1.79* 2.25K Nov 10, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TTOO Restricted Stock Units Options Exercise $0 -3.33K -33.33% $0.00 6.67K Nov 8, 2022 Common Stock 3.33K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 The sale reported in this Form 4 was made in order to pay the tax liability arising from vesting and settlement of RSU's on November 8, 2022. The sale was effected through an automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person.
F3 On February 26, 2022 the reporting person was granted 10,000 RSU's that vest in three substantially equal installments on November 8, 2022, November 8, 2023, and October 1, 2024.